Works by Landewé, Robert B M

Results: 39
    1
    2
    3
    4
    5
    6

    Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.

    Published in:
    Rheumatology & Therapy, 2023, v. 10, n. 1, p. 53, doi. 10.1007/s40744-022-00498-x
    By:
    • Combe, Bernard G.;
    • Tanaka, Yoshiya;
    • Buch, Maya H.;
    • Nash, Peter;
    • Burmester, Gerd R.;
    • Kivitz, Alan J.;
    • Bartok, Beatrix;
    • Pechonkina, Alena;
    • Xia, Katrina;
    • Emoto, Kahaku;
    • Kano, Shungo;
    • Hendrikx, Thijs K.;
    • Landewé, Robert B. M.;
    • Aletaha, Daniel
    Publication type:
    Article
    7
    8
    9

    The Concept of Axial Spondyloarthritis: Joint Statement of the Spondyloarthritis Research and Treatment Network and the Assessment of SpondyloArthritis international Society in Response to the US Food and Drug Administration's Comments and Concerns.

    Published in:
    Arthritis & Rheumatology, 2014, v. 66, n. 10, p. 2649, doi. 10.1002/art.38776
    By:
    • Deodhar, Atul;
    • Reveille, John D.;
    • Bosch, Filip;
    • Braun, Jürgen;
    • Burgos‐Vargas, Ruben;
    • Caplan, Liron;
    • Clegg, Daniel O.;
    • Colbert, Robert A.;
    • Gensler, Lianne S.;
    • Heijde, Désirée;
    • Horst‐Bruinsma, Irene E.;
    • Inman, Robert D.;
    • Maksymowych, Walter P.;
    • Mease, Philip J.;
    • Raychaudhuri, Siba;
    • Reimold, Andreas;
    • Rudwaleit, Martin;
    • Sieper, Joachim;
    • Weisman, Michael H.;
    • Landewé, Robert B. M.
    Publication type:
    Article
    10
    11
    12

    Reply.

    Published in:
    2021
    By:
    • Rusman, Tamara;
    • van der Weijden, Mignon A. C.;
    • Nurmohamed, Michael T.;
    • van der Bijl, Carmella M. A.;
    • van der Laken, Conny J.;
    • Bet, Pierre M.;
    • Landewé, Robert B. M.;
    • de Winter, Janneke J. H.;
    • Boden, Bouke J. H.;
    • van der Horst‐Bruinsma, Irene E.
    Publication type:
    Letter to the Editor
    13
    14
    15
    16
    17
    18

    Progression From Subclinical Inflammation to Overt Spondyloarthritis in First‐Degree Relatives of Patients in Association With HLA–B27: The Pre‐Spondyloarthritis Cohort.

    Published in:
    Arthritis Care & Research, 2022, v. 74, n. 12, p. 2076, doi. 10.1002/acr.24743
    By:
    • de Jong, Henriëtte M. Y.;
    • de Winter, Janneke J. H.;
    • van der Horst‐Bruinsma, Irene E.;
    • van Schaardenburg, Dirk‐Jan;
    • van Gaalen, Floris A.;
    • van Tubergen, Astrid M.;
    • Weel, Angelique E. A. M.;
    • Landewé, Robert B. M.;
    • Baeten, Dominique L. P.;
    • van de Sande, Marleen G. H.
    Publication type:
    Article
    19
    20

    Impact of Stopping Tumor Necrosis Factor Inhibitors on Rheumatoid Arthritis Patients' Burden of Disease.

    Published in:
    2018
    By:
    • Ghiti Moghadam, Marjan;
    • ten Klooster, Peter M.;
    • Vonkeman, Harald E.;
    • Kneepkens, Eva L.;
    • Klaasen, Ruth;
    • Stolk, Jan N.;
    • Tchetverikov, Ilja;
    • Vreugdenhil, Simone A.;
    • van Woerkom, Jan M.;
    • Goekoop‐Ruiterman, Yvonne P. M.;
    • Landewé, Robert B. M.;
    • van Riel, Piet L. C. M.;
    • van de Laar, Mart A. F. J.;
    • Jansen, Tim L.;
    • the Dutch National POET Collaboration;
    • Goekoop-Ruiterman, Yvonne P M;
    • Dutch National POET Collaboration
    Publication type:
    journal article
    21
    22

    Single dose tocilizumab for COVID‐19 associated cytokine storm syndrome: Less is more.

    Published in:
    British Journal of Clinical Pharmacology, 2025, v. 91, n. 4, p. 938, doi. 10.1111/bcp.15690
    By:
    • Boone, Niels W.;
    • Moes, Dirk Jan A. R.;
    • Ramiro, Sofia;
    • Mostard, Remy L. M.;
    • Magro‐Checa, Cesar;
    • van Dongen, Christel M. P.;
    • Gronenschild, Michiel;
    • van Haren, Eric;
    • Buijs, Jacqueline;
    • de Vries, Annick;
    • Peeters, Ralph;
    • Landewé, Robert B. M.;
    • Wong, Dennis R.
    Publication type:
    Article
    23

    Hemocytometric characteristics of COVID-19 patients with and without cytokine storm syndrome on the sysmex XN-10 hematology analyzer.

    Published in:
    Clinical Chemistry & Laboratory Medicine, 2021, v. 59, n. 4, p. 783, doi. 10.1515/cclm-2020-1529
    By:
    • Martens, Remy J. H.;
    • van Adrichem, Arjan J.;
    • Mattheij, Nadine J. A.;
    • Brouwer, Calvin G.;
    • van Twist, Daan J. L.;
    • Broerse, Jasper J. C. R.;
    • Magro-Checa, César;
    • van Dongen, Christel M. P.;
    • Mostard, Rémy L. M.;
    • Ramiro, Sofia;
    • Landewé, Robert B. M.;
    • Leers, Math P. G.
    Publication type:
    Article
    24
    25
    26
    27
    28
    29

    Predictors of biologic-free disease control in patients with rheumatoid arthritis after stopping tumor necrosis factor inhibitor treatment.

    Published in:
    BMC Rheumatology, 2019, v. 3, n. 1, p. N.PAG, doi. 10.1186/s41927-019-0071-x
    By:
    • Ghiti Moghadam, Marjan;
    • Lamers-Karnebeek, Femke B. G.;
    • Vonkeman, Harald E.;
    • ten Klooster, Peter M.;
    • Tekstra, Janneke;
    • van Schaeybroeck, Barbara;
    • Klaasen, Ruth;
    • van Onna, Marieke;
    • Bernelot Moens, Hein J.;
    • Visser, Henk;
    • Schilder, Annemarie M.;
    • Kok, Marc R.;
    • Landewé, Robert B. M.;
    • van Riel, Piet L. C. M.;
    • van de Laar, Mart A. F. J.;
    • Jansen, Tim L.
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39